Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4
US-12589094-B2 · Mar 31, 2026 · US
Corcept Therapeutics Inc holds 260 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 260 |
| Recent patents | 94 |
| First publication | Mar 5, 2015 |
| Latest publication | Mar 31, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12589094-B2 · Mar 31, 2026 · US
US-2026069586-A1 · Mar 12, 2026 · US
US-2026014141-A1 · Jan 15, 2026 · US
US-2026007653-A1 · Jan 8, 2026 · US
US-12514849-B2 · Jan 6, 2026 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12589094-B2 · Mar 31, 2026 · US
US-2026069586-A1 · Mar 12, 2026 · US
US-2026014141-A1 · Jan 15, 2026 · US
US-2026007653-A1 · Jan 8, 2026 · US
US-12514849-B2 · Jan 6, 2026 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 255 |
| Chemistry & Metallurgy | 90 |
| Physics | 46 |
Answers are generated from the same data shown on this page.